Mortality analysis of COVID-19 infection in chronic kidney disease, haemodialysis and renal transplant patients compared with patients without kidney disease: a nationwide analysis from Turkey.

---

Atıf İçin Kopyala

Ozturk S., Turgutalp K., Arici M., Odabas A. R., Altiparmak M. R., Aydin Z., ...Daha Fazla

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, cilt.35, ss.2083-2095, 2020 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 35
• Basım Tarihi: 2020
• Doi Numarası: 10.1093/ndt/gfaa271
• Dergi Adı: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
• Sayfa Sayıları: ss.2083-2095
• Anahtar Kelimeler: COVID-19, haemodialysis, kidney disease, mortality, renal transplantation, REPLACEMENT, POPULATION, OUTCOMES, RISK
• Recep Tayyip Erdoğan Üniversitesi Adresli: Evet

Özet

Background. Chronic kidney disease (CKD) and immunosuppression, such as in renal transplantation (RT), stand as one of the established potential risk factors for severe coronavirus disease 2019 (COVID-19). Case morbidity and mortality rates for any type of infection have always been much higher in CKD, haemodialysis (HD) and RT patients than in the general population. A large study comparing COVID-19 outcome in moderate to advanced CKD (Stages 3-5), HD and RT patients with a control group of patients is still lacking.